| Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01204034) | University Hospital, Antwerp | 2010-09-01 |
| Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients (NCT01204970) | KU Leuven | 2010-09-01 |
| Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation (NCT01380652) | Schön Klinik Berchtesgadener Land | 2010-09-01 |
| Effects of Vibration Training on Exercise Capacity in COPD-patients (NCT01380639) | Schön Klinik Berchtesgadener Land | 2010-09-01 |
| Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension? (NCT01197469) | University of Dundee | 2010-09-01 |
| Effects of Home-based Pulmonary Rehabilitation in Patients With Severe or Very Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01198288) | Associazione Riabilitatori Insufficienza Respiratoria | 2010-09-01 |
| Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) (NCT01176318) | Hull University Teaching Hospitals NHS Trust | 2010-08-10 |
| Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure (NCT01174316) | ResMed | 2010-08-01 |
| Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA) (NCT01285167) | AstraZeneca | 2010-08-01 |
| Quadricipital Electrical Stimulation in COPD Patients Rehabilitation (NCT02171377) | University Hospital, Rouen | 2010-08-01 |
| Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02948582) | Sunovion Respiratory Development Inc. | 2010-07-01 |
| Antibiotic or Not in Non-purulent Exacerbations of COPD: a Trial of Security and Efficacy (NCT01091493) | Fundacion Clinic per a la Recerca Biomédica | 2010-07-01 |
| SCOPE-Study: Salzburg Chronic Obstructive Pulmonary Disease- Exercise and Oxygen Study (NCT01150383) | Paracelsus Medical University | 2010-07-01 |
| Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand (NCT01169727) | AstraZeneca | 2010-07-01 |
| Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) (NCT01145300) | Leiden University Medical Center | 2010-06-01 |
| Evaluating Forced Oscillation Technique (FOT) in Abolishing Flow Limitation (NCT01151618) | Philips Respironics | 2010-06-01 |
| Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients. (NCT01329276) | University Hospital, Antwerp | 2010-06-01 |
| Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01154127) | Novartis Pharmaceuticals | 2010-06-01 |
| An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease (NCT01146392) | AstraZeneca | 2010-06-01 |
| Triage of Reduced Exercise Tolerance in Frail Elderly (NCT01148719) | UMC Utrecht | 2010-05-01 |
| Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients (NCT01119937) | Novartis Pharmaceuticals | 2010-05-01 |
| Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD) (NCT01116063) | Carmel Medical Center | 2010-05-01 |
| Efficacy of Helium/Oxygen Compared to Air/Oxygen in Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) (NCT01155310) | Air Liquide Santé International | 2010-05-01 |
| Determination of the in Vitro Effects of Cationic Airway Lining Modulators (CALM) on Chronic Obstructive Pulmonary Disease (COPD) Sputum (NCT01096173) | Pulmatrix Inc. | 2010-04-01 |
| Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations (NCT01120691) | Novartis Pharmaceuticals | 2010-04-01 |
| Effect of Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist (NAVA) in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00568100) | Policlinico Hospital | 2010-04-01 |
| A Study to Assess the Long-term Safety of QVA149 (NCT01120717) | Novartis Pharmaceuticals | 2010-04-01 |
| Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease (NCT01110564) | AstraZeneca | 2010-04-01 |
| Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01119950) | Novartis Pharmaceuticals | 2010-04-01 |
| Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD (NCT01108991) | The University of Texas Health Science Center at Tyler | 2010-04-01 |
| Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) (NCT01089127) | Novartis Pharmaceuticals | 2010-03-01 |
| Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients (NCT02331940) | University of Crete | 2010-03-01 |
| Ventilator Settings and Comfort (NCT01131390) | Bridgeport Hospital | 2010-03-01 |
| Characterization of Aerosol Generation and Transport in the Human Lung of Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01088633) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2010-03-01 |
| Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01085045) | Pearl Therapeutics, Inc. | 2010-03-01 |
| The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01364181) | Seoul National University Hospital | 2010-03-01 |
| Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START) (NCT01797367) | University of Minnesota | 2010-03-01 |
| An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease (NCT00974805) | University of Southampton | 2010-02-01 |
| This Study Will Investigate How Food and Age Effect the Way the Body Handles the AZD5069 Drug Given as a Oral Dose (NCT01083238) | AstraZeneca | 2010-02-01 |
| Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients (NCT01380626) | Schön Klinik Berchtesgadener Land | 2010-02-01 |
| Validation of HealthCare Standards in Chronic Obstructive Pulmonary Disease (NCT01544543) | Sociedad Española de Neumología y Cirugía Torácica | 2010-02-01 |
| Mindfulness Based Stress Reduction in COPD (NCT01058499) | Mayo Clinic | 2010-02-01 |
| Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM) (NCT01099410) | VA Office of Research and Development | 2010-02-01 |
| Chronic Obstructive Pulmonary Disease (COPD) Activity: Serotonin Transporter (SERT), Cytokines and Depression (CASCADE Study) (NCT01074515) | University of Washington | 2010-02-01 |
| A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01068184) | AstraZeneca | 2010-02-01 |
| Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol Fumarate (NCT01078623) | AstraZeneca | 2010-02-01 |
| Effects of Rehabilitation on Muscle Fibre Composition and Capillaries in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01715337) | Schön Klinik Berchtesgadener Land | 2010-02-01 |
| Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease Sufferers in the Region of Murcia (NCT01380470) | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 2010-02-01 |
| IVR-Enhanced Care Transition Support for Complex Patients (NCT01135381) | University of Alabama at Birmingham | 2010-02-01 |
| Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7) (NCT01068145) | Merck Sharp & Dohme LLC | 2010-02-01 |
| Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions (NCT02135744) | Henry Ford Health System | 2010-02-01 |
| Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks (NCT01068600) | Novartis | 2010-01-01 |
| 12-week Efficacy of Indacaterol (NCT01072448) | Novartis | 2010-01-01 |
| Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD) (NCT00974220) | Queen's University | 2010-01-01 |
| Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01068613) | Novartis Pharmaceuticals | 2010-01-01 |
| Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler® (NCT01048333) | AstraZeneca | 2010-01-01 |
| Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients (NCT00446121) | Imperial College London | 2010-01-01 |
| The Canadian Cohort Obstructive Lung Disease (NCT00920348) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2010-01-01 |
| Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD): the Development and Feasibility of an Education Package (NCT01226836) | University of Ulster | 2010-01-01 |
| Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01069289) | AstraZeneca | 2010-01-01 |
| The Doses of Systemic Steroid in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) (NCT01215825) | Far Eastern Memorial Hospital | 2010-01-01 |
| Multiparametric Telemonitoring In Elderly People With Chronic Obstructive Pulmonary Disease (NCT01481506) | Campus Bio-Medico University | 2010-01-01 |
| Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo (NCT01049360) | AstraZeneca | 2009-12-01 |
| Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01047553) | AstraZeneca | 2009-12-01 |
| Neurally Adjusted Ventilatory Assist and Synchrony in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01042080) | Hôpital Européen Marseille | 2009-12-01 |
| Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies (NCT01363531) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2009-12-01 |
| Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction (NCT01041586) | Uptake Medical Corp | 2009-12-01 |
| Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01131806) | Taipei Veterans General Hospital, Taiwan | 2009-12-01 |
| AZD9668 Relative Bioavailability (NCT01034982) | AstraZeneca | 2009-11-01 |
| Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35) (NCT01044459) | AstraZeneca | 2009-11-01 |
| Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01013142) | MediciNova | 2009-11-01 |
| Continuous Positive Airway Pressure Effect on Air Trapping in Chronic Obstructive Pulmonary Disease Patients (NCT01507844) | Assaf-Harofeh Medical Center | 2009-11-01 |
| Coventry Outcomes Study of Seniors (COSS): A Comparative Effectiveness Study to Evaluate the Effect of a Multidisciplinary Team's Intervention on the Incidence of Nonelective Hospitalizations in a Medicare Population (NCT01014884) | Medco Health Solutions, Inc. | 2009-11-01 |
| Mechanisms of Vascular Damage in Patients With Chronic Obstructive Pulmonary Disease (NCT01020344) | University of Zurich | 2009-11-01 |
| Symptom Clusters and Immune Markers in Patients With Chronic Obstructive Pulmonary Disease (COPD) - a Longitudinal Study (NCT01016587) | Oslo University Hospital | 2009-11-01 |
| Effect of Indacaterol on Inspiratory Capacity (IC) (NCT01012765) | Novartis Pharmaceuticals | 2009-11-01 |
| AZD9668 Relative Bioavailability (NCT01035411) | AstraZeneca | 2009-11-01 |
| Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01007734) | AstraZeneca | 2009-10-01 |
| Patient-Ventilator Interactions in Chronic Obstructive Pulmonary Diseases (COPD) Under Non-Invasive Ventilation (NCT01180439) | Ligue Pulmonaire Genevoise | 2009-10-01 |
| Signaling Pathway Activation After Exercise in Patients With Chronic Obstructive Pulmonary Disease (NCT01561625) | Laval University | 2009-10-01 |
| Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD) (NCT01014338) | Imperial College London | 2009-10-01 |
| Deep High-Frequency Repetitive Transcranial Magnetic Stimulation for Smoking Cessation (NCT00951782) | BeerYaakov Mental Health Center | 2009-10-01 |
| A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting (NCT01013922) | AstraZeneca | 2009-10-01 |
| A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo (NCT01005901) | Novartis | 2009-10-01 |
| Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity (NCT00999908) | Novartis Pharmaceuticals | 2009-10-01 |
| EAA Intake to Optimize Protein Anabolism in COPD (NCT01173354) | Texas A&M University | 2009-09-08 |
| A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease (NCT00992680) | ROX Medical, Inc. | 2009-09-01 |
| Asthma & COPD Guideline Implementation (NCT01766544) | Laval University | 2009-09-01 |
| Well Being and Rehabilitation in Chronically Ill Patients: Structured Patient Education and Physical Exercise (NCT00989456) | Norwegian University of Science and Technology | 2009-09-01 |
| Oral Cyclosporine in Chronic Obstructive Pulmonary Disease (NCT00974142) | Michael Donahoe | 2009-09-01 |
| Interaction in Chronic Obstructive Pulmonary Disease Experiment (NCT00981851) | Radboud University Medical Center | 2009-09-01 |
| Trial of Vitamin D Supplementation in Chronic Obstructive Pulmonary Disease (NCT00977873) | Barts & The London NHS Trust | 2009-09-01 |
| Long-term Impact of Pulmonary Rehabilitation (NCT00959855) | Beaumont Hospital | 2009-09-01 |
| Pulmonary Rehabilitation in COPD: Effects of Two Aerobic Exercise Intensity in Patient-centered Outcomes (NCT01944072) | Universidade Nova de Lisboa | 2009-09-01 |
| The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough (NCT01071161) | Isala | 2009-09-01 |
| Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD) (NCT00958919) | Dartmouth-Hitchcock Medical Center | 2009-08-01 |
| Benefits Study of Respiratory-gated PET Acquisition in Lung Disease (NCT01812031) | Centre Hospitalier Universitaire, Amiens | 2009-08-01 |
| Telehealth Monitoring in Chronic Obstructive Pulmonary Disease (NCT01522859) | South Eastern Health and Social Care Trust | 2009-08-01 |
| Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36) (NCT00970268) | AstraZeneca | 2009-08-01 |
| Effect of Supplemental Oxygen on Maximal Oxygen Consumption in Patients With Chronic Obstructive Pulmonary Disease (NCT01294033) | Beth Israel Deaconess Medical Center | 2009-08-01 |